Its proprietary and differentiated lipid nanoparticle (LNP) platform is a cornerstone in advancing next-generation messenger ...

Developing novel drugs is a notoriously lengthy and costly process, with a failure rate of about 90 percent. The process typically takes about 10 years and costs $1 billion on average, according to ...

CHARLESTON, S.C. (WCSC) - The Trump administration started to cut funding from messenger ribonucleic acid vaccine research earlier this month, impacting more than 20 contracts for vaccine development.

In a recent study published in Nature Communications, researchers proposed a simplified approach for analyzing messenger ribonucleic acid (mRNA) vaccines using long-read sequencing. Messenger RNA ...

Scientists say they have developed a nanoparticle -- an extremely tiny biodegradable container -- that has the potential to improve the delivery of messenger ribonucleic acid (mRNA)-based vaccines for ...

Abstract: In one important chemical engineering unit operation of messenger ribonucleic acid (mRNA) vaccine manufacture, the precious mRNA payload is encapsulated in lipid nanoparticles. Recent ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and implications for molecular biology research.

A single enzyme that can generate all four nucleotide triphosphates, the building blocks of ribonucleic acid (RNA), was ...